Company / Operating Income per Share
Larimar Therapeutics, Inc. Operating Income per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.42
FY2019
5-year range
-$2.70 / -$0.60
FY2015-FY2019
Trend
+32.9%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-2.70 to $-1.42 over the past 2 years.
Based on SEC 10-K filings.
-1.42 in FY2019.
Improved from $-2.70 to $-1.42 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, operating income per share increased 32.9% year-over-year.
- Peak operating income per share was recorded in FY2015.
- Lowest operating income per share in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | -$1.42 | +32.9% |
| FY2018 | -$2.12 | +21.6% |
| FY2017 | -$2.70 | -107.1% |
| FY2016 | -$1.30 | -116.6% |
| FY2015 | -$0.60 | +96.8% |
| FY2014 | -$18.91 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026